Safety and efficacy of trifluridine/tipiracil plus bevacizumab in RAS mutated patients with metastatic colorectal cancer

被引：0
|
作者：
Michalaki, Vasiliki
Theodosopoulos, Thedosios
Vezakis, Antonios
Papaconstantinou, Ioannis
Kontis, Ioannis
Dafnios, Nikolaos
Frangoulidis, George
Karandrea, Despina
Papadimitriou, Christos
机构：
[1] Natl & Kapodistrian Univ Athens, Aretaieion Hosp, Sch Med, Dept Surg 2, Athens, Greece
[2] Aretaieion Hosp, Dept Surg 2, Athens, Greece
[3] Natl & Kapodistrian Univ, Aretaieion Hosp, Dept Surg 2, Athens, Greece
[4] Univ Athens, Aretaieion Hosp, Dept Surg 2, Athens, Greece
[5] Natl & Kapodistrian Univ Athens, Aretaieion Hosp, Oncol, Dept Surg 2, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15605
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Metastatic Colorectal Cancer Management with trifluridine/tipiracil
    White, Teresa
    Larson, Heidi
    Minnella, Alexandra
    Hochster, Howard S.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : E30 - E37
  • [42] Bevacizumab improves efficacy of trifluridine/tipiracil (TAS-102) in patients with chemorefractory metastatic colorectal cancer: a Danish randomized trial
    Pfeiffer, P.
    Yilmaz, M.
    Moller, S.
    Zitnjak, D.
    Maltha, L.
    Krogh, M.
    Winther, S.
    Petersen, L.
    Hejlersen, F.
    Thomsen, K.
    Qvortrup, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [43] Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer
    Hara, Shinsuke
    Sakai, Daisuke
    Ikemura, Kenji
    Shintani, Takuya
    Yamamoto, Tomoya
    Satoh, Taroh
    Okuda, Masahiro
    ANTICANCER RESEARCH, 2024, 44 (03) : 1219 - 1226
  • [44] Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer
    Doleschal, B.
    Taghizadeh, H.
    Lentner, T.
    Riedl, J. M.
    Granitzer, J.
    Morariu, D.
    Decker, J.
    Aichberger, K. J.
    Webersinke, G.
    Kirchweger, P.
    Petzer, A.
    Rumpold, H.
    ESMO OPEN, 2023, 8 (06)
  • [45] Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer–single institutional experience
    Mashiro Okunaka
    Akihito Kawazoe
    Hitomi Nakamura
    Daisuke Kotani
    Saori Mishima
    Yasutoshi Kuboki
    Yoshiaki Nakamura
    Kohei Shitara
    Gastric Cancer, 2023, 26 : 1030 - 1039
  • [46] Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer
    Prager, Gerald W.
    Taieb, Julien
    Fakih, Marwan
    Ciardiello, Fortunato
    Cutsem, Eric Van
    Elez, Elena
    Wyrwicz, Lucjan
    Stroyakovskiy, Daniil
    Liposits, Gabor
    Bondarenko, Igor
    Modest, Dominik P.
    Amellal, Nadia
    Tabernero, Josep
    FUTURE ONCOLOGY, 2024, 20 (36) : 2823 - 2832
  • [47] Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis
    Basso, Michele
    Signorelli, Carlo
    Calegari, Maria Alessandra
    Lucchetti, Jessica
    Zurlo, Ina Valeria
    Dell'Aquila, Emanuela
    Arrivi, Giulia
    Zoratto, Federica
    Santamaria, Fiorenza
    Saltarelli, Rosa
    Trovato, Giovanni
    Caira, Giulia
    Angotti, Lorenzo
    Schirripa, Marta
    Anghelone, Annunziato
    Schietroma, Francesco
    Chilelli, Mario Giovanni
    Salvatore, Lisa
    Pozzo, Carmelo
    Tortora, Giampaolo
    TARGETED ONCOLOGY, 2024, 19 (03) : 371 - 382
  • [48] Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study
    Van Cutsem, E.
    Danielewicz, I
    Saunders, M. P.
    Pfeiffer, P.
    Argiles, G.
    Borg, C.
    Glynne-Jones, R.
    Punt, C. J. A.
    Van de Wouw, A. J.
    Fedyanin, M.
    Stroyakovskiy, D.
    Kroening, H.
    Garcia-Alfonso, P.
    Wasan, H.
    Falcone, A.
    Kanehisa, A.
    Egorov, A.
    Aubel, P.
    Amellal, N.
    Moiseenko, V
    ANNALS OF ONCOLOGY, 2020, 31 (09) : 1160 - 1168
  • [49] Regorafenib and trifluridine/tipiracil efficacy and safety in chemorefractory metastatic colorectal cancer patients: A single Bulgarian centre retrospective study
    Penkova, M.
    Stoyanov, D.
    Panayotova, T.
    Donev, I.
    Petrova, M.
    Conev, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S100 - S100
  • [50] Trifluridine/tipiracil plus capecitabine and bevacizumab as upfront treatment for metastatic colorectal cancer: Results of the phase 1 TriComB study
    Cirac, Paolo
    Conca, Veronica
    Moretto, Roberto
    Antoniotti, Carlotta
    Ambrosini, Margherita
    Murgioni, Sabina
    Gori, Giovanni
    Russo, Alessandra
    Bergamo, Francesca
    Randon, Giovanni
    Studiale, Vittorio
    Fini, Elisabetta
    Marmorino, Federica
    Borelli, Beatrice
    Germani, Marco Maria
    Vetere, Guglielmo
    Carullo, Martina
    Boccaccio, Chiara
    Masi, Gianluca
    Cremolini, Chiara
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345